Maximilian Stahl (@maxstahlmd) 's Twitter Profile
Maximilian Stahl

@maxstahlmd

Director Leukemia Program @Yale @YaleCancer @SmilowCancer
Prior @DanaFarber @harvardmed @MSKCancerCenter @TradIMYale

ID: 1372629451218038792

calendar_today18-03-2021 19:22:25

155 Tweet

784 Followers

290 Following

Busem Binboga Kurt (@busembkurt) 's Twitter Profile Photo

One of the most brilliant, curious, and compassionate young physicians I have ever known is applying for #IMresidency this year #Match2025 🤩. I am super excited for you Nurefsan Sariipek, MD ! I wish you all the best of luck, our future oncologist 🥺

VJHemOnc (@vjhemonc) 's Twitter Profile Photo

Watch our interview with Benjamin Rolles, MD of@BrighamWomens to hear about an analysis assessing the impact of response to HMA-based therapy on survival outcomes in patients with HR-MDS. Click here: 👉 ow.ly/oO5T50UsrrO 👈 #MDSsm #HemOnc #ASH24 ASH

OncLive.com (@onclive) 's Twitter Profile Photo

Maximilian Stahl, MD, discusses unmet needs in relapsed/refractory AML, highlighting the potential utility menin inhibitors in select populations. Maximilian Stahl Dana-Farber #leusm #oncology onclive.com/view/menin-inh…

OncLive.com (@onclive) 's Twitter Profile Photo

Menin inhibitors such as revumenib could address unmet needs in the treatment of patients with relapsed/refractory AML harboring KMT2A rearrangements or NPM1 mutations. Maximilian Stahl Dana-Farber #leusm #oncology onclive.com/view/menin-inh…

Menin inhibitors such as revumenib could address unmet needs in the treatment of patients with relapsed/refractory AML harboring KMT2A rearrangements or NPM1 mutations. <a href="/MaxStahlMD/">Maximilian Stahl</a> <a href="/DanaFarber/">Dana-Farber</a> #leusm #oncology onclive.com/view/menin-inh…
IACH (@theiach) 's Twitter Profile Photo

📽️Now on demand! Our latest IACH Post #ASH24 webinar Dedicated to AML with Maximilian Stahl Watch the full webinar for FREE👇 iach.org/post-congress-… Maximilian Stahl Mohamad Mohty

Maximilian Stahl (@maxstahlmd) 's Twitter Profile Photo

🌟 Excited to join the 29th Annual Acute Leukemia Forum in La Jolla, CA, April 3-4! Connect with leading experts and 📚explore the latest treatments. Register now for groundbreaking insights! 🧬events.medscapelive.org/website/74912/… #ALFLive25

Abdulrahman Alhajahjeh, MD (@alhajahjeh_abd) 's Twitter Profile Photo

Our latest review explores the emerging role of Myeloid-Derived Suppressor Cells (MDSCs) in AML & MDS, GVHD modulation & therapeutic targeting. Big thanks to my amazing mentors Jan Bewersdorf, Maximilian Stahl & Amer Zeidan MBBS,MHS ‏عامر زيدان 🙏 📖 doi.org/10.1080/147371… #AML #MDS #ImmunoOncology

Our latest review explores the emerging role of Myeloid-Derived Suppressor Cells (MDSCs) in AML &amp; MDS, GVHD modulation &amp; therapeutic targeting.

Big thanks to my amazing mentors Jan Bewersdorf, <a href="/MaxStahlMD/">Maximilian Stahl</a> &amp; <a href="/Dr_AmerZeidan/">Amer Zeidan MBBS,MHS ‏عامر زيدان</a> 🙏

📖 doi.org/10.1080/147371…
#AML #MDS  #ImmunoOncology
Maximilian Stahl (@maxstahlmd) 's Twitter Profile Photo

Bitter sweet goodbye on my last day Dana-Farber. I was lucky to have the best colleagues and so many patients who have inspired me! My fav impression from DFCI: The beams of the clinic building has the names of patients quite literally forming the foundation of everything we do!

Bitter sweet goodbye on my last day <a href="/DanaFarber/">Dana-Farber</a>. I was lucky to have the best colleagues and so many patients who have inspired me! My fav impression from DFCI: The beams of the clinic building has the names of patients quite literally forming the foundation of everything we do!
Oncology News Central (@oncnewscentral) 's Twitter Profile Photo

“7 + 3” in AML may soon be history. Maximilian Stahl predicts a major shift toward #TargetedTherapies—like the menin inhibitor #Revumenib—for newly diagnosed #AML. bit.ly/4iPPZS7 #Hematology #Oncology #LeukemiaCare Dana-Farber

Maximilian Stahl (@maxstahlmd) 's Twitter Profile Photo

Excited to join the team Yale Cancer Center and Smilow Cancer Hospital as the Director of the Leukemia Program. Yale University has been my home away from home ever since I came here as a medical student many years ago. medicine.yale.edu/news-article/h…

Excited to join the team <a href="/YaleCancer/">Yale Cancer Center</a> and <a href="/SmilowCancer/">Smilow Cancer Hospital</a> as the Director of the Leukemia Program. <a href="/Yale/">Yale University</a> has been my home away from home ever since I came here as a medical student many years ago.  medicine.yale.edu/news-article/h…
Maximilian Stahl (@maxstahlmd) 's Twitter Profile Photo

🗽Join me in NYC this summer to explore the most controversial clinical issues in the field of hematologic malignancies! Network with local experts and bring best practices back to your clinic. Register for free using my last name as a discount code: shorturl.at/Cdsdf